HealthSouth Corp. (HLS) Given Average Recommendation of “Buy” by Brokerages
HealthSouth Corp. (NYSE:HLS) has been assigned an average recommendation of “Buy” from the twelve ratings firms that are currently covering the stock. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. The average 12 month price objective among analysts that have issued ratings on the stock in the last year is $46.13.
HLS has been the topic of several recent analyst reports. Wells Fargo & Co. reiterated a “buy” rating on shares of HealthSouth Corp. in a report on Sunday, September 11th. Zacks Investment Research cut HealthSouth Corp. from a “buy” rating to a “hold” rating in a research note on Friday, August 5th. Barclays PLC cut HealthSouth Corp. from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $45.00 to $42.00 in a research note on Monday, June 27th. They noted that the move was a valuation call. SunTrust Banks Inc. set a $54.00 target price on HealthSouth Corp. and gave the company a “buy” rating in a research note on Monday, August 1st. Finally, JMP Securities restated a “buy” rating on shares of HealthSouth Corp. in a research note on Sunday, September 4th.
HealthSouth Corp. (NYSE:HLS) traded down 1.17% during midday trading on Tuesday, hitting $40.46. The stock had a trading volume of 189,864 shares. HealthSouth Corp. has a 1-year low of $30.26 and a 1-year high of $43.38. The firm has a 50-day moving average price of $40.66 and a 200-day moving average price of $39.95. The firm has a market capitalization of $3.63 billion, a price-to-earnings ratio of 17.76 and a beta of 1.02.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/11/healthsouth-corp-hls-given-average-recommendation-of-buy-by-brokerages.html
HealthSouth Corp. (NYSE:HLS) last released its quarterly earnings data on Thursday, July 28th. The company reported $0.69 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.60 by $0.09. HealthSouth Corp. had a return on equity of 28.99% and a net margin of 6.26%. The business had revenue of $920.70 million for the quarter, compared to analysts’ expectations of $906.67 million. During the same quarter in the previous year, the business posted $0.47 EPS. HealthSouth Corp.’s revenue for the quarter was up 20.4% on a year-over-year basis. On average, equities research analysts anticipate that HealthSouth Corp. will post $2.52 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Monday, October 3rd will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, September 29th. This is a positive change from HealthSouth Corp.’s previous quarterly dividend of $0.23. This represents a $0.96 dividend on an annualized basis and a dividend yield of 2.34%. HealthSouth Corp.’s payout ratio is presently 42.29%.
In related news, COO Mark J. Tarr sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 2nd. The stock was sold at an average price of $41.85, for a total transaction of $837,000.00. Following the transaction, the chief operating officer now directly owns 252,519 shares of the company’s stock, valued at approximately $10,567,920.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 5.00% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of HLS. Creative Planning raised its position in HealthSouth Corp. by 2.0% in the second quarter. Creative Planning now owns 2,858 shares of the company’s stock worth $111,000 after buying an additional 56 shares during the last quarter. Baird Financial Group Inc. raised its position in HealthSouth Corp. by 1.1% in the second quarter. Baird Financial Group Inc. now owns 7,281 shares of the company’s stock worth $283,000 after buying an additional 76 shares during the last quarter. S. R. Schill & Associates raised its position in HealthSouth Corp. by 0.7% in the second quarter. S. R. Schill & Associates now owns 11,052 shares of the company’s stock worth $429,000 after buying an additional 76 shares during the last quarter. Sasco Capital Inc. CT raised its position in HealthSouth Corp. by 1.1% in the second quarter. Sasco Capital Inc. CT now owns 23,783 shares of the company’s stock worth $923,000 after buying an additional 260 shares during the last quarter. Finally, US Bancorp DE raised its position in HealthSouth Corp. by 1.5% in the second quarter. US Bancorp DE now owns 17,985 shares of the company’s stock worth $698,000 after buying an additional 264 shares during the last quarter. 94.94% of the stock is currently owned by institutional investors and hedge funds.
HealthSouth Corp. Company Profile
HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in over 30 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company’s segments include inpatient rehabilitation, and home health and hospice.
Receive News & Ratings for HealthSouth Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corp. and related companies with MarketBeat.com's FREE daily email newsletter.